Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-lesional 3% polidocanol for treatment of digital myxoid cysts
2013-005338-39Phase 4Terminated
- Sponsor
- University of Edinburgh
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of 10XB101 in digital mucous cyst (3 arms), sponsored by University of Edinburgh. Primary endpoint: Cyst resolution at 6 weeks. Started Jun 2014; status: terminated.
02
Drugs
10XB101
03
Conditions
digital mucous cyst
Beyond the preview
Go deeper on 2013-005338-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005338-39.